Rekombinanter IGF1R (Dalotuzumab Biosimilar) Antikörper
Research Grade
Reaktivität: Human
ELISA
Wirt: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Target
- IGF1R (Dalotuzumab Biosimilar)
- Antikörpertyp
- Recombinant Antibody
- Reaktivität
- Human
- Wirt
-
Mammalian Cells
- Expressionssystem
- Mammalian cells
- Klonalität
- Monoklonal
- Applikation
- ELISA
- Verwendungszweck
- Dalotuzumab Biosimilar - Anti-IGF1R, CD221 mAb
- Produktmerkmale
- Antibody Type: IgG1-kappa
- Aufreinigung
- Recombinant antibody expressed in mammalien cells and purified.
- Güteklasse
- Research Grade
- Isotyp
- IgG1 kappa
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Buffer
- PBS pH 7.5
- Lagerung
- -80 °C
- Informationen zur Lagerung
- store at -80°C
-
- Target
- IGF1R (Dalotuzumab Biosimilar)
- Substanzklasse
- Biosimilar
- Hintergrund
-
MK-0646
Dalotuzumab (MK-0646; h7C10), is a recombinant humanized IgG1 mAb against the IGF1R for the potential intravenous treatment of cancer, including Breast Cancer, Non-Small Cell Lung Cancer, and Metastatic Colorectal Cancer. - CAS-Nummer
- 1005389-60-5
-
Sie sind hier:
